Factors Influencing Stent Failure in Chronic Total Occlusion Coronary Intervention

Overview

Journal Interv Cardiol

Date 2021 Nov 1

PMID 34721666

Citations 3

Authors

Kalaivani Mahadevan

Claudia Cosgrove

Julian W Strange

Affiliations

Soon will be listed here.

Abstract

Stent failure remains one of the greatest challenges for interventional cardiologists. Despite the evolution to superior second- and third-generation drug-eluting stent designs, increasing use of intracoronary imaging and the adoption of more potent antiplatelet regimens, registries continue to demonstrate a prevalence of stent failure or target lesion revascularisation of 15-20%. Predisposition to stent failure is consistent across both chronic total occlusion (CTO) and non-CTO populations and includes patient-, lesion- and procedure-related factors. However, histological and pathophysiological properties specific to CTOs, alongside complex strategies to treat these lesions, may potentially render percutaneous coronary interventions in this cohort more vulnerable to failure. Prevention requires recognition and mitigation of the precipitants of stent failure, optimisation of interventional techniques, including image-guided precision percutaneous coronary intervention, and aggressive modification of a patient's cardiovascular risk factors. Management of stent failure in the CTO population is technically challenging and itself begets recurrence. We aim to provide a comprehensive review of factors influencing stent failure in the CTO population and strategies to attenuate these.

Citing Articles

Stent Crumpling as a Complication of Percutaneous Coronary Intervention, a Case Report and Literature Review.

Mehrpooya M, Vahidi H, Taheri M, Ebrahimi P Clin Case Rep. 2025; 13(2):e70212.

PMID: 39935653 PMC: 11810625. DOI: 10.1002/ccr3.70212.

Coronary Dissection - Back to the Future - Finding Good in the Bad!.

Natarajan R, Corballis N, Merinopoulos I, Vassiliou V, Eccleshall S Heart Int. 2025; 18(2):14-23.

PMID: 39885932 PMC: 11781370. DOI: 10.17925/HI.2024.18.2.5.

Retrospective analysis of the drug-coated balloon-only strategy for chronic total occlusion coronary lesions.

Li P, Li H, Cheng Y, Meng X, Yang C, Li H J Thorac Dis. 2024; 16(8):5314-5322.

PMID: 39268116 PMC: 11388238. DOI: 10.21037/jtd-24-969.

Predictors of long-term adverse outcomes after successful chronic total occlusion intervention: physiology or morphology?.

Elbasha K, Alotaibi S, Heyer H, Mankerious N, Toelg R, Geist V Clin Res Cardiol. 2023; 113(7):977-986.

PMID: 37542021 DOI: 10.1007/s00392-023-02279-0.

Stent underexpansion is associated with high wall shear stress: a biomechanical analysis of the shear stent study.

Kumar S, Molony D, Khawaja S, Crawford K, Thompson E, Hung O Int J Cardiovasc Imaging. 2023; 39(7):1375-1382.

PMID: 37119348 DOI: 10.1007/s10554-023-02838-6.

References

Salisbury A, Sapontis J, Grantham J, Qintar M, Gosch K, Lombardi W . Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Diabetes: Insights From the OPEN CTO Registry. JACC Cardiovasc Interv. 2017; 10(21):2174-2181. DOI: 10.1016/j.jcin.2017.08.043. View

Popma J, Tiroch K, Almonacid A, Cohen S, Kandzari D, Leon M . A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol. 2009; 103(7):923-9. DOI: 10.1016/j.amjcard.2008.12.022. View

Mohr F, Morice M, Kappetein A, Feldman T, Stahle E, Colombo A . Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013; 381(9867):629-38. DOI: 10.1016/S0140-6736(13)60141-5. View

Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F, Hausleiter J . Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 2003; 41(8):1283-8. DOI: 10.1016/s0735-1097(03)00119-0. View

Kim B, Shin D, Hong M, Park H, Rha S, Mintz G . Clinical Impact of Intravascular Ultrasound-Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation: Randomized Study. Circ Cardiovasc Interv. 2015; 8(7):e002592. DOI: 10.1161/CIRCINTERVENTIONS.115.002592. View

Ladwiniec A, Allgar V, Thackray S, Alamgir F, Hoye A . Medical therapy, percutaneous coronary intervention and prognosis in patients with chronic total occlusions. Heart. 2015; 101(23):1907-14. DOI: 10.1136/heartjnl-2015-308181. View

Azzalini L, Dautov R, Brilakis E, Ojeda S, Benincasa S, Bellini B . Impact of crossing strategy on midterm outcomes following percutaneous revascularisation of coronary chronic total occlusions. EuroIntervention. 2017; 13(8):978-985. DOI: 10.4244/EIJ-D-16-01010. View

Michael T, Mogabgab O, Alomar M, Kotsia A, Christopoulos G, Rangan B . Long-term outcomes of successful chronic total occlusion percutaneous coronary interventions using the antegrade and retrograde approach. J Interv Cardiol. 2014; 27(5):465-71. DOI: 10.1111/joic.12149. View

Bonaa K, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygard O . Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. N Engl J Med. 2016; 375(13):1242-52. DOI: 10.1056/NEJMoa1607991. View

10.

Williams P, Mamas M, Morgan K, El-Omar M, Clarke B, Bainbridge A . Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms. EuroIntervention. 2011; 8(2):267-74. DOI: 10.4244/EIJV8I2A41. View

11.

Abe M, Morimoto T, Morino Y, Tanaka H, Akao M, Hayashi Y . Association between J-CTO score and long-term target lesion revascularization rate after successful chronic total coronary occlusion angioplasty (from the J-CTO Registry). Catheter Cardiovasc Interv. 2019; 93(6):1025-1032. DOI: 10.1002/ccd.28104. View

12.

Chieffo A, Latib A, Caussin C, Presbitero P, Galli S, Menozzi A . A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J. 2012; 165(1):65-72. DOI: 10.1016/j.ahj.2012.09.017. View

13.

Stolker J, Cohen D, Kennedy K, Pencina M, Lindsey J, Mauri L . Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012; 5(6):772-82. DOI: 10.1161/CIRCINTERVENTIONS.111.967802. View

14.

Rhee T, Park K, Lee J, Lee M, Jeon K, Kang H . Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort. Circ Cardiovasc Interv. 2017; 10(11). DOI: 10.1161/CIRCINTERVENTIONS.117.005518. View

15.

Azzalini L, Ojeda S, Karatasakis A, Maeremans J, Tanabe M, La Manna A . Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients Who Have Undergone Coronary Artery Bypass Grafting vs Those Who Have Not. Can J Cardiol. 2018; 34(3):310-318. DOI: 10.1016/j.cjca.2017.12.016. View

16.

Watson T, Webster M, Ormiston J, Ruygrok P, Stewart J . Long and short of optimal stent design. Open Heart. 2017; 4(2):e000680. PMC: 5663262. DOI: 10.1136/openhrt-2017-000680. View

17.

Matsuo Y, Kubo T, Aoki H, Satogami K, Ino Y, Kitabata H . Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis. Catheter Cardiovasc Interv. 2015; 87(1):E9-E14. DOI: 10.1002/ccd.26143. View

18.

Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schuhlen H, Neumann F . Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001; 103(23):2816-21. DOI: 10.1161/01.cir.103.23.2816. View

19.

Ali Z, Galougahi K, Nazif T, Maehara A, Hardy M, Cohen D . Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J. 2016; 37(40):3090-3095. PMC: 6279210. DOI: 10.1093/eurheartj/ehw078. View

20.

Doi H, Maehara A, Mintz G, Yu A, Wang H, Mandinov L . Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv. 2010; 2(12):1269-75. DOI: 10.1016/j.jcin.2009.10.005. View